Jan 17, 2023Press Release 2023Cosmos Health Provides an Update on its Debt Balance and Proforma Interest ExpenseCosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense Reduced its debt by 78% from $21.2M in 2021 to $4.6M...
Jan 9, 2023Press Release 2023Cosmos Health Extends and Updates its Agreement to Acquire Cana LaboratoriesCosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company Vertically Integrating...
Jan 4, 2023Press Release 2023Cosmos Health Regains Nasdaq Minimum Bid Price ComplianceCosmos Health announced today that it has successfully cured the Nasdaq minimum bid price deficiency.
Dec 21, 2022Press Release 2022Cosmos Health CEO Participated in the Last Fundraising of the CompanyCosmos Health announced today that CEO Greg Siokas has participated with $3 million in the approximately $32.5 million financing
Dec 18, 2022Press Release 2022Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct OfferingCosmos Health announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale